The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial
- PMID: 12932243
- DOI: 10.1046/j.1365-2133.2003.05435.x
The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial
Abstract
Background: Recent studies of antidandruff shampoos or tonics containing antifungal or antibacterial agents produced effects suggestive of a potential hair growth benefit.
Objectives: The purpose of this 6-month, 200-patient, randomized, investigator-blinded, parallel-group clinical study was to assess the hair growth benefits of a 1% pyrithione zinc shampoo. The efficacy of a 1% pyrithione zinc shampoo (used daily), was compared with that of a 5% minoxidil topical solution (applied twice daily), a placebo shampoo and a combination of the 1% pyrithione zinc shampoo and the 5% minoxidil topical solution.
Methods: Two hundred healthy men between the ages of 18 and 49 years (inclusive) exhibiting Hamilton-Norwood type III vertex or type IV baldness were enrolled. Total hair counts, the primary efficacy measure, were obtained using fibre-optic microscopy and a computer-assisted, manual hair count method. Secondary measures of efficacy included assessments of hair diameter, as well as patient and investigator global assessments of improvement in hair growth. These were based on photographs of the scalp using both midline and vertex views.
Results: Hair count results showed a significant (P < 0.05) net increase in total visible hair counts for the 1% pyrithione zinc shampoo, the 5% minoxidil topical solution, and the combination treatment groups relative to the placebo shampoo after 9 weeks of treatment. The relative increase in hair count for the 1% pyrithione zinc shampoo was slightly less than half that for the minoxidil topical solution and was essentially maintained throughout the 26-week treatment period. No advantage was seen in using both the 5% minoxidil topical solution and the 1% pyrithione zinc shampoo. A small increase in hair diameter was observed for the minoxidil-containing treatment groups at week 17. Assessments of global improvements by the patients and investigator generally showed the benefit of 5% minoxidil. The benefit of the 1% pyrithione zinc shampoo used alone tended (P < 0.1) to be apparent only to the investigator.
Conclusions: Hair count results show a modest and sustained improvement in hair growth with daily use of a 1% pyrithione zinc shampoo over a 26-week treatment period.
Similar articles
-
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014. J Am Acad Dermatol. 2004. PMID: 15034503 Clinical Trial.
-
Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.Am J Clin Dermatol. 2007;8(5):285-90. doi: 10.2165/00128071-200708050-00003. Am J Clin Dermatol. 2007. PMID: 17902730 Clinical Trial.
-
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20. J Eur Acad Dermatol Venereol. 2018. PMID: 29972712 Clinical Trial.
-
Topical minoxidil therapy for hair regrowth.Clin Pharm. 1987 May;6(5):386-92. Clin Pharm. 1987. PMID: 3311578 Review.
-
Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis.J Dermatolog Treat. 2025 Dec;36(1):2447355. doi: 10.1080/09546634.2024.2447355. Epub 2025 Jan 19. J Dermatolog Treat. 2025. PMID: 39828269
Cited by
-
Zinc Deficiency and Zinc Supplementation in Allergic Diseases.Biomolecules. 2024 Jul 19;14(7):863. doi: 10.3390/biom14070863. Biomolecules. 2024. PMID: 39062576 Free PMC article. Review.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. J Cosmet Dermatol. 2021. PMID: 34741573 Free PMC article. Review.
-
Minoxidil-Coated Lysozyme-Shelled Microbubbes Combined With Ultrasound for the Enhancement of Hair Follicle Growth: Efficacy In Vitro and In Vivo.Front Pharmacol. 2021 Apr 27;12:668754. doi: 10.3389/fphar.2021.668754. eCollection 2021. Front Pharmacol. 2021. PMID: 33986689 Free PMC article.
-
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.Am J Clin Dermatol. 2014 Apr;15(2):115-27. doi: 10.1007/s40257-013-0060-6. Am J Clin Dermatol. 2014. PMID: 24474647 Free PMC article. Clinical Trial.
-
Nanocrystal Structure of Minoxidil: A Safe Stimulator for Hair Growth Factor for C57BL/6 Mice.Curr Med Chem. 2025;32(21):4343-4355. doi: 10.2174/0109298673283413240116065844. Curr Med Chem. 2025. PMID: 38362689
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical